Phillips AN - Search Results

1

Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.

Lodi S, Günthard HF, Dunn D, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Schneider MP, Egger M, Glass TR, Reiss P, van Sighem A, Boender TS, Phillips AN, Porter K, Hawkins D, Moreno S, Monge S, Paraskevis D, Simeon M, Vourli G, Sabin C, Hernán MA; HIV-CAUSAL Collaboration. Lodi S, et al. Among authors: phillips an. AIDS. 2018 Jan 28;32(3):327-335. doi: 10.1097/QAD.0000000000001692. AIDS. 2018. PMID: 29135583 Free PMC article.

2

Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort.

Phillips A, Lee CA, Elford J, Janossy G, Bofill M, Timms A, Kernoff PB. Phillips A, et al. AIDS. 1989 Nov;3(11):737-41. doi: 10.1097/00002030-198911000-00008. AIDS. 1989. PMID: 2575912

3

CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.

Sabin C, Pasi J, Phillips A, Elford J, Janossy G, Lee C. Sabin C, et al. Thromb Haemost. 1994 Aug;72(2):214-7. Thromb Haemost. 1994. PMID: 7831654

4

The progression of HIV disease in a haemophilic cohort followed for 12 years.

Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C. Sabin C, et al. Br J Haematol. 1993 Feb;83(2):330-3. doi: 10.1111/j.1365-2141.1993.tb08290.x. Br J Haematol. 1993. PMID: 8384472

5

CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.

Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, Timms A, Batista L, Winter M, Sabin CA, Johnson M, Lee CA, Phillips A, Janossy G. Mocroft A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):158-62. doi: 10.1097/00042560-199702010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052725

6

Trial design in the era of highly effective antiviral drug combinations for HIV infection.

DeGruttola V, Hughes M, Gilbert P, Phillips A. DeGruttola V, et al. AIDS. 1998;12 Suppl A:S149-56. AIDS. 1998. PMID: 9632997 Review. No abstract available.

7

Virological response to protease inhibitor therapy in an HIV clinic cohort.

Staszewski S, Miller V, Sabin C, Carlebach A, Berger AM, Weidmann E, Helm EB, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 Feb 25;13(3):367-73. doi: 10.1097/00002030-199902250-00009. AIDS. 1999. PMID: 10199227

8

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.

Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, Leder T, Berger A, Weidemann E, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 May 28;13(8):951-6. doi: 10.1097/00002030-199905280-00011. AIDS. 1999. PMID: 10371176

9

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.

DeGruttola V, Dix L, D'Aquila R, Holder D, Phillips A, Ait-Khaled M, Baxter J, Clevenbergh P, Hammer S, Harrigan R, Katzenstein D, Lanier R, Miller M, Para M, Yerly S, Zolopa A, Murray J, Patick A, Miller V, Castillo S, Pedneault L, Mellors J. DeGruttola V, et al. Antivir Ther. 2000 Mar;5(1):41-8. doi: 10.1177/135965350000500112. Antivir Ther. 2000. PMID: 10846592

10

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.

Miller V, Sabin C, Hertogs K, Bloor S, Martinez-Picado J, D'Aquila R, Larder B, Lutz T, Gute P, Weidmann E, Rabenau H, Phillips A, Staszewski S. Miller V, et al. AIDS. 2000 Dec 22;14(18):2857-67. doi: 10.1097/00002030-200012220-00007. AIDS. 2000. PMID: 11153667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

522 results

Search Page